Group structure
9 companies in 5 countries
Loading your page…
Loading your page…
9 companies in 5 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 27
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| COGNEX10mg base | 20mg base | 30mg base | 40mg base · Capsule | Tacrina | United States | Not marketed | 1993 |
| DORIBAX250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Doripenem | United States | Not marketed | 2007 |
| EDARAVONE105 mg / 5 ml · Suspension | Edaravone | Canada | Authorised | |
| Fetcroja | Cefiderocol | EU (EMA) | Authorised | 2020 |
| FETCROJAPolvere per concentrato per soluzione per infusione | Cefiderocol | Italy | Authorised | |
| Fetcroja 1 g, poeder voor concentraat voor oplossing voor infusiePoeder voor concentraat voor oplossing voor infusie | Cefiderocol | Netherlands | Authorised | 2020 |
| FETCROJA 1 G POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION1563.8 mg · Polvo para concentrado para solución para perfusión | Cefiderocol | Spain | Marketed | 2020 |
| FETROJA1gm base/vial · Powder | Cefiderocol | United States | Marketed | 2019 |
| MULPLEO 3 MG COMPRIMIDOS RECUBIERTOS CON PELICULA3.0 mg · Comprimido recubierto con película | Lusutrombopag | Spain | Authorised | 2019 |
| Mulpleo (previously Lusutrombopag Shionogi) | Lusutrombopag | EU (EMA) | Authorised | 2019 |
| RADICAVA30mg/100ml (0.3mg/ml) | 60mg/100ml (0.6mg/ml) · Solution | Edaravone | United States | Not marketed | 2017 |
| RADICAVA105 mg / 5 ml · Suspension | Edaravone | Canada | Marketed | 2023 |
| RADICAVA ORS105mg/5ml · Suspension | Edaravone | United States | Marketed | 2022 |
| Rizmoic | Naldemedine | EU (EMA) | Authorised | 2019 |
| RIZMOICCompressa rivestita con film | Naldemedine | Italy | Authorised | |
| Rizmoic 200 microgram, filmomhulde tabletFilmomhulde tablet | Naldemedine | Netherlands | Authorised | 2019 |
| RIZMOIC 200 MICROGRAMOS COMPRIMIDOS RECUBIERTOS CON PELICULA260.4 µg · Comprimido recubierto con película | Naldemedine | Spain | Marketed | 2019 |
| RYBIX ODT50mg · Tablet, orally disintegrating | Tramadol | United States | Not marketed | 2005 |
| SENSHIOCompressa rivestita con film | Ospemifene | Italy | Authorised | |
| Senshio | Ospemifene | EU (EMA) | Authorised | 2015 |
| SENSHIO 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA60 mg · Comprimido recubierto con película | Ospemifene | Spain | Marketed | 2015 |
| Senshio 60 mg filmomhulde tablettenFilmomhulde tablet | Ospemifene | Netherlands | Authorised | 2015 |
| ULESFIA5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Lotion | Benzyl alcohol | United States | Not marketed | 2009 |
| UROBAK500mg · Tablet | Sulfamethoxazole | United States | Not marketed | |
| UROPLUS DS800mg; 160mg · Tablet | Sulfamethoxazole, Trimethoprim | United States | Not marketed |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 10 | 10 | 0 | CompaniesAll medicines |
| Spain | 4 | 4 | 0 | CompaniesAll medicines |
| European Union (EMA) | 4 | 4 | 0 | CompaniesAll medicines |
| Italy | 3 | 3 | 0 | CompaniesAll medicines |
| Netherlands | 3 | 3 | 0 | CompaniesAll medicines |
| Canada | 2 | 2 | 0 | CompaniesAll medicines |
| Saudi Arabia | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of Brazil, France, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from ACRA Information on Corporate Entities, accessed on 8 October 2026 through Data.gov.sg, under Singapore Open Data Licence version 1.0: https://data.gov.sg/open-data-licence. Structured selection and normalisation by Prognia; original UEN, field and retrieval date retained.
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.